Latisha Samuel, | |
2550 Immokalee Rd, Naples, FL 34110-1410 | |
(239) 594-7015 | |
Not Available |
Full Name | Latisha Samuel |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 2550 Immokalee Rd, Naples, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003416173 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | PS33752 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Latisha Samuel, 2550 Immokalee Rd, Naples, FL 34110-1410 Ph: (239) 594-7015 | Latisha Samuel, 2550 Immokalee Rd, Naples, FL 34110-1410 Ph: (239) 594-7015 |
News Archive
Middle school children who have a television or computer in their room sleep less during the school year, watch more TV, play more computer games and surf the net more than their peers who don't - reveals joint research conducted by the University of Haifa and Jezreel Valley College.
An initiative that would bring health insurance rate regulation to California has qualified for the November 2014 ballot, setting the stage for a vigorous and costly battle between insurers and consumer groups. The measure, sponsored by Consumer Watchdog, would give the state insurance commissioner the power to deny certain premium increases if they are deemed excessive.
RevMed has secured a binding 5 Year contract to produce 5M syringes/month of its 3mL fixed needle safety syringe with Medical Investment Group, LLC (MIG). MIG, a Massachusetts Limited Liability Company, will fulfill this obligation through its relationship with an internationally certified global medical device manufacturer.
The objective of this roadmap was to feature the drivers, needs and future potential for various actors involved in the food production and distribution chain, but also for actors developing services offering communication and motivation tools for consumers who wish to improve their nutrition.
Shire plc announces that the U.S. Food and Drug Administration has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.
› Verified 4 days ago
Jaclyn Cheadle, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1565 Airport Rd S, Naples, FL 34104 Phone: 239-435-0454 | |
Marc A Kepner, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2200 9th St N, Naples, FL 34103 Phone: 239-263-0240 Fax: 239-263-8545 | |
Dr. Matthew Sanger, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8300 Collier Blvd, Naples, FL 34114 Phone: 239-354-6063 Fax: 239-354-6062 | |
Dr. Abdel Rahman Taha, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4860 Davis Blvd, Naples, FL 34104 Phone: 239-732-7318 | |
Dr. Bradley Armand Regnaert, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11190 Health Park Blvd, Pharmacy Department, Naples, FL 34110 Phone: 239-513-7002 | |
Mr. Mark Pittman, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2310 Pine Ridge Rd, Naples, FL 34109 Phone: 239-435-0489 Fax: 239-435-0382 |